Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Philips HIC introduces...

    Philips HIC introduces INTUIS- Entry level Cath Labs in India

    Written by Geeta Sharma Sharma Published On 2016-03-04T12:28:50+05:30  |  Updated On 4 March 2016 12:28 PM IST
    Philips HIC introduces INTUIS- Entry level Cath Labs in India

    Pune: The India manufacturing unit of Netherlands Royal Philips got an impetus today with the launch Intuis , an entry level catheterization lab. The aim of launching "Intuis", being o provide tier II and tier III cities with affordable cardiac care. The equipment is completely designed developed and manufactured in India by Philips Healthcare Innovation Center (HIC) in Pune.The cath lab is the sixth product launched by the centre in Pune for its Indian and global market.The company will export cath labs to global markets of Latin America, Africa and Western Europe.


    Talking to Business Standard,Bert Van Meurs, General Manager, Image Guided Therapy at Philips said "This is the sixth Philips product which is entirely designed, developed and manufactured in India. We are looking at India as a global supply base for our products. Our strategy is to build a mature organisation in India. We are also expanding our mobile surgery portfolio in Pune for global markets. There is room for further expansion as well. We are also designing and manufacturing general imaging and mammography
    portfolio,"

    Speaking about company products, Mr. Meurs said that 50% of the mobile surgery products were developed in Netherlands while the other 50 in Pune. He revealed that they had a large number of products on their portfolio and some of the general X ray's were being designed and developed here. Besides diagnostic products, the company, he stated was also planning to manufacture some consumer market focused products in India.

    Elaborating on the companies future plans the General Manager stated that besides designing and developing high end diagnostic products in India they were also planning to use indigenous components in their products. The earlier 20% localisation of components had increased to become 40% today, according to Mr. Meurs. Philips India presently is catering to 80 emerging and several Western European markets according to Rekha Ranganathan, General Manager, Mobile Surgery,Philips image guided therapy systems and head of Philips HIC.

    According to Ms. Ranganathan , Intuis due of its indigenous character had a competitive advantage of 25 -30% over other products of a similar kind."This need is felt acutely in tier-II cities, where the availability of effective healthcare infrastructure is often a challenge. With Philips Intuis, we are addressing the evolving needs of cardiologists and patients beyond metro's and tier-I cities," she added.


    According to Meurs, the Philip India's hub journey for its products began after it acquired Mumbai-based Alpha X-Ray Technologies in September, 2008."The reason why we came here was the capability to design for value. Taking a premium system and stripping it down for other markets will never work and our engineers in the Netherlands do not have the capability to design from bottom-up a value product. Our India centre capability and engineers are equipped to design in that fashion," added Meurs.

    Philips HIC , Pune manufactures both interventional and diagnostic X-Ray systems. The center has successfully installed over 1,000 systems in more than 80 different countries, including countries in Western Europe. Since 2012, HIC has launched five global products -- MobileDiagnost Opta, Allura FC, Allura Centron, BV Vectra and Primary Diagnost.

    Philips has changed the name of its health care division in Pune to Healthcare Innovation Centre (HIC) from its earlier Development Manufacturing Centre as part of their innovation plans.

    Bert Van Meurscath labentry level catheterization labHealthcare Innovation CentreHICINTUISPhilipsRoyal Philips
    Source : Inputs from Business Standard

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok